{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-167951","form_type":"8-K","ticker":"MIRM","cik":"0001759425","company_name":"Mirum Pharmaceuticals, Inc.","filed_at":"2022-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.197942+00:00","generated_at":"2026-06-25T04:26:00.558429+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Mirum appoints Saira Ramasastry to board; stockholders re-elect three directors","bullets":["Saira Ramasastry appointed to Mirum's board effective June 2, 2022; will serve on audit committee.","Ramasastry received option to purchase 34,000 shares vesting over three years; annual cash retainers of $40k (board) and $10k (audit).","At annual meeting, stockholders re-elected directors Laura Brege, Michael Grey, and Christopher Peetz to Class III terms expiring 2025.","Stockholders ratified Ernst & Young as independent auditor for FY2022 with overwhelming support."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-167951","json":"https://secwatch.observer/filing/0001193125-22-167951.json","markdown":"https://secwatch.observer/filing/0001193125-22-167951.md","text":"https://secwatch.observer/filing/0001193125-22-167951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/0001193125-22-167951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/d309554d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:26:00.558429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"31a0ea326f","claim":"Saira Ramasastry was appointed as Director at Mirum Pharmaceuticals, Inc..","evidence_excerpt":"On June 2, 2022, the Board of Directors (the \"Board\") of Mirum Pharmaceuticals, Inc. (the \"Company\"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Saira Ramasastry to the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759425/000119312522167951/0001193125-22-167951-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}